HIF1A and neoplasm: Ji et al. revealed that ALDOA boosted pancreatic cancer's aggressiveness and metastatic potential by enhancing glycolysis and activating oxidative stress responses, impacting key factors such as c-Myc, HIF1α, and NRF2, thereby promoting tumor growth and spread 219.